Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Jezik
Vsa polja
Naslov
Avtor
Tema
Signatura
ISBN/ISSN
Oznaka
Išči
Napredno
Rationale and design of the Tr...
Citiraj
Pošljite SMS
Pošljite email
Natisni
Izvozi zadetek
Izvozi v RefWorks
Izvozi v EndNoteWeb
Izvozi v EndNote
Permanent link
Rationale and design of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
Bibliografske podrobnosti
Main Authors:
Bethel, M
,
Green, J
,
Califf, R
,
Holman, R
Format:
Conference item
Izdano:
2009
Zaloga
Opis
Podobne knjige/članki
Knjižničarski pogled
Podobne knjige/članki
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
od: Green, J, et al.
Izdano: (2013)
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.
od: Green, J, et al.
Izdano: (2013)
Assessing the safety of sitagliptin in older participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
od: Bethel, M, et al.
Izdano: (2017)
Pancreatic safety of sitagliptin in the TECOS Study.
od: Buse, J, et al.
Izdano: (2016)
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS Trial.
od: Josse, R, et al.
Izdano: (2016)